Nasal drug delivery device
AssigneeImpel Neuropharma, Inc.
InventorsChristopher William FULLER, Craig Frederick KOHRING, Albert Kenneth LAVIN, John D. HOEKMAN
Life of this patent
Estimating the term…
Loading patent…
AssigneeImpel Neuropharma, Inc.
InventorsChristopher William FULLER, Craig Frederick KOHRING, Albert Kenneth LAVIN, John D. HOEKMAN
Estimating the term…
A nasal drug delivery device for delivering a plume derived from a propellant and a drug compound. The drug corn-pound is in an intranasal dosage form in the form of powder, suspension, dispersion, or liquid. The propelled intranasal dosage form is deposited within the upper nasal cavity such as the olfactory region. The drug deposited within the olfactory region is delivered to the brain avoiding the blood-brain-barrier. Hydrofluoroalkane propellant from a pressurized canister is channeled to a diffuser and drug-containing channel where the intranasal dosage form is aerosolized. The aerosolized intranasal dosage form passes through a nozzle thus delivering a plume to the user's upper nasal cavity.
A device for delivering a compound to an upper nasal cavity comprising:
A device for delivering a compound to an upper nasal cavity comprising:
A nozzle for delivering a compound to an upper nasal cavity comprising:
Dependencies are inferred from the claim text.